Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The functional neuro-anatomical model of attachment (NAMA) proposes that the balance between affective evaluation and cognitive control systems can be modulated by adult attachment styles and attachment priming. However, little is known about the characteristics of emotional conflict control that are modulated by attachment patterns. Accordingly, the present study adopted two experiments to investigate the associations between attachment styles, attachment (in)security priming, and emotional conflict control. Experiment 1 (= 225) examined the association between attachment styles and emotional interference, demonstrating that individuals high on attachment anxiety (AX) relied more on affective evaluation to hinder conflict control. Furthermore, Experiment 2 (= 185) explored the effect of attachment priming on emotional conflict control. Moderated mediation models indicated that high sense of attachment security mediated the relationship between security priming and increased emotional interference when it interacted with high AX. Additionally, high sense of insecurity partially mediated the association between threat priming and reduced emotional interference only for individuals with high AX, while low AX strengthened the effect of threat priming on decreased emotional interference. Together, these findings provide supporting evidence for the NAMA that the emotional-cognitive balance in emotional conflict control is modulated by both attachment styles and attachment priming.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02699931.2025.2476679DOI Listing

Publication Analysis

Top Keywords

conflict control
24
attachment styles
20
emotional conflict
20
styles attachment
16
emotional interference
16
attachment
14
attachment priming
12
emotional
9
attachment insecurity
8
priming
8

Similar Publications

Background: Peripheral nerve injury commonly results in pain and long-term disability for patients. Recovery after in-continuity stretch or crush injury remains inherently unpredictable. However, surgical intervention yields the most favorable outcomes when performed shortly after injury.

View Article and Find Full Text PDF

Recent Advances in Gene Therapy for Hemophilia.

Clin Appl Thromb Hemost

September 2025

Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.

Hemophilia, an X-linked monogenic disorder, arises from mutations in the or genes, which encode clotting factor VIII (FVIII) or clotting factor IX (FIX), respectively. As a prominent hereditary coagulation disorder, hemophilia is clinically manifested by spontaneous hemorrhagic episodes. Severe cases may progress to complications such as stroke and arthropathy, significantly compromising patients' quality of life.

View Article and Find Full Text PDF

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a fairly new class of agents for diabetes that have demonstrated significant benefits in glycemic control and cardiovascular outcomes with outpatient use. The aim of this review is to provide an overview of the effect of SGLT2i use on glycemic control and clinical outcomes in the hospital setting.An electronic search of PubMed was conducted to analyze publications that assessed the inpatient use of SGLT2i and included patients with diabetes.

View Article and Find Full Text PDF

Background: Lung cancer (LC) is the leading cause of cancer-related deaths globally. Genetic variants in mismatch repair (MMR) genes, such as MutS homolog 2 (MSH2), MutS homolog 6 (MSH6) and MutL homolog 1 (MLH1), may influence individual susceptibility and clinical outcomes in LC.

Objective: This study investigated the associations of genetic polymorphisms in MSH2, MSH6, and MLH1 with susceptibility and survival outcomes in lung cancer patients in the Guangxi Zhuang population.

View Article and Find Full Text PDF

The COVID-19 pandemic, caused by the continuously evolving SARS-CoV-2 virus, has presented persistent global health challenges. As novel variants emerge, many with enhanced transmissibility and immune evasion capabilities, concerns have intensified regarding the efficacy of existing vaccines and therapeutics. This review provides a comprehensive overview of the current landscape of COVID-19 vaccination, including the development and performance of monovalent and bivalent boosters, and examines their effectiveness against newly emerging variants of interest (VOIs) and variants under monitoring (VUMs), such as JN.

View Article and Find Full Text PDF